ArticleJournal of gynecologic oncology2026

Efficacy and toxicity of PARP inhibitor in elderly patients with homologous recombination-deficient newly diagnosed advanced ovarian cancer: the role of dose modification.

Ji Hyun Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.